Dr Peter Chow
NationalitySingaporean
GenderMale
Age49 (As at 5 April 2024)
Dr Peter Chow was appointed Chief Executive Officer of IHH Healthcare Singapore from 1 April 2024. He spearheads strategic initiatives and drives operational excellence across IHH's business units in Singapore, which include Gleneagles, Mount Elizabeth, Mount Elizabeth Novena, and Parkway East hospitals, the primary healthcare group Parkway Shenton, Parkway MediCentre Woodleigh, as well as ancillary and education entities such as Parkway Radiology, Parkway Rehab, Parkway Cancer Centre, and Parkway College. Prior to this appointment, Dr Chow held the position of Acting Chief Executive Officer of IHH Singapore from 1 October 2023.
Dr Chow joined IHH in 2018 and was appointed as Chief Executive Officer of Mount Elizabeth Novena Hospital in 2020. Despite challenges from the Covid-19 pandemic, he led the hospital through a period of strategic development and growth, strengthening its position as a regional centre of clinical excellence. He was awarded the Public Service Medal (Covid-19) and Covid-19 Resilience Medal in 2022 and 2023 respectively for his healthcare leadership role during the pandemic and for supporting various national pandemic efforts in Singapore.
Dr Chow has over 20 years of healthcare management experience spanning both public and private sectors in Singapore. Trained as a dental surgeon with the National University of Singapore, he started his career as a dental officer. Subsequently he took on different management roles including quality, training, manpower, as well as managed outpatient clinical services, giving him broad-based experience in healthcare.
Prior to IHH, he was with National Healthcare Group (NHG) during which he assumed various roles including Director of Quality & College, Director of Corporate Development & Communications and Chief Operating Officer of NHG Polyclinics.